This program was captured live at the NACE Emerging Challenges in Primary Care Series Update 2007 and features Dr. Phyliss Zee. Dr. Phyllis Zee. Dr. Zee is Professor of Neurology and Neurobiology and Physiology at Northwestern University in Chicago, Illinois. Please visit www.naceonline.com for more information.
Learning Objective
The learning objective for this webcast is utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life.
Faculty Disclosure
Dr. Zee receives grant support from the National Institutes of Heath, Boehringer Ingelheim, Sanofi-Aventis, Kyowa, Schwartz Biosciences, Takeda Pharmaceuticals of North America. She is a consultant for Boehringer Ingelheim, Sanofi-Aventis, Takeda Pharmaceuticals of North America, Neurocrine Biosciences, and Pfizer. She is on the speaker's burea for Takeda Pharmaceuticals of North America nad Sanofi-Aventis.
To find additional information about this webcast and others offered by the National Association for Continuing Education, please visit us at: www.naceonline.com.
Approximate running time 55 min.
Click here to view segment 1 of this webcast.
Click here to view segment 2 of this webcast.
